MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Perrigo Co PLC

Geschlossen

BrancheGesundheitswesen

24.88 0.48

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

24.5

Max

25.08

Schlüsselkennzahlen

By Trading Economics

Einkommen

-24M

-45M

Verkäufe

51M

1.1B

KGV

Branchendurchschnitt

2,570

57.333

EPS

0.93

Dividendenrendite

4.76

Gewinnspanne

-3.909

Angestellte

8,379

EBITDA

35M

114M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+39.45% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

4.76%

2.63%

Nächstes Ergebnis

7. Mai 2025

Nächste Dividendenausschüttung

17. Juni 2025

Nächstes Ex-Dividendendatum

29. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

85M

3.5B

Vorheriger Eröffnungskurs

24.4

Vorheriger Schlusskurs

24.88

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Perrigo Co PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Feb. 2025, 17:42 UTC

Wichtige Markttreiber

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27. Feb. 2025, 23:52 UTC

Ergebnisse

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Peer-Vergleich

Kursveränderung

Perrigo Co PLC Prognose

Kursziel

By TipRanks

39.45% Vorteil

12-Monats-Prognose

Durchschnitt 34.5 USD  39.45%

Hoch 42 USD

Tief 27 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Perrigo Co PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

4 ratings

2

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

24.09 / 24.825Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.